Cleared Traditional

K952494 - DIGITAL ELECTRONIC WRIST BLOOD PRESSURE MONITOR

K952494 is an FDA 510(k) clearance for DIGITAL ELECTRONIC WRIST BLOOD PRESSURE..., manufactured by Nihon Seimitsu Sokki Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 212-day FDA review.

K952494 · Nihon Seimitsu Sokki Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1995
Decision
212d
Days
Class 2
Risk

K952494 is an FDA 510(k) clearance for the DIGITAL ELECTRONIC WRIST BLOOD PRESSURE MONITOR. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Nihon Seimitsu Sokki Co., Ltd. (Shibukawa-Shi, Gunma-Ken, JP). The FDA issued a Cleared decision on December 28, 1995 after a review of 212 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Nihon Seimitsu Sokki Co., Ltd. devices

FDA 510(k) Submission Details - K952494

510(k) Number K952494 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 30, 1995
Decision Date December 28, 1995
Days to Decision 212 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
87d slower than avg
Panel avg: 125d · This submission: 212d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 844
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K952494.
OMRON, LUMISCOPE, LABTRON, MEDI - SOURCE, BAXTER
K955342 · Rashman Corp. · Jun 1996
CLINICAL VITAL SIGNS MONITOR, MODEL #52STP-E1
K951193 · Tycos Instruments, Inc. · Mar 1996
MARS DIGITAL BLOOD PRESSURE MONITOR
K945215 · Mars Metal Co., Ltd. · Jan 1996
NELLCOR SYMPHONY N-3100 BLOOD PRESSURE MONITOR
K953472 · Nellcor, Inc. · Oct 1995
NELLCOR SYMPHONY(TM) N-3100 BLOOD PRESSURE MONITOR AND CONNECTED TO THE NELLCOR SYMPHONY(TM) N-3000 PULSE OXIMETER
K945947 · Nellcor, Inc. · Mar 1995
TRIMLINE 2000
K943081 · Pymah Corp. · Jan 1995